Xi

CGTN: China-Africa friendship continues to flourish on vaccine, trade, renewable energy

Retrieved on: 
Tuesday, November 30, 2021

Elaborating on the secret of China-Africa friendship and looking to the future development of their relations, he highlighted unity against the pandemic, deepening practical cooperation, promoting green development, and safeguarding fairness and justice.

Key Points: 
  • Elaborating on the secret of China-Africa friendship and looking to the future development of their relations, he highlighted unity against the pandemic, deepening practical cooperation, promoting green development, and safeguarding fairness and justice.
  • After COVID-19 struck Africa, China supplied 50 African countries and the AU Commission with COVID-19 vaccines.
  • China will work with Africa to expand trade and investment, share experience in poverty alleviation, and strengthen cooperation on digital economy and renewable energy, Xi said.
  • FOCAC now has 55 members, comprising China, the 53 African countries that have diplomatic relations with China, and the AU Commission.

EQRx to Present at the 4th Annual Evercore ISI HealthCONx Conference

Retrieved on: 
Monday, November 29, 2021

EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced that management will participate in a fireside chat at the 4th Annual Evercore ISI HealthCONx Conference.

Key Points: 
  • EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced that management will participate in a fireside chat at the 4th Annual Evercore ISI HealthCONx Conference.
  • EQRx is a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices.
  • In August 2021, EQRx announced a proposed combination with CM Life Sciences III (Nasdaq: CMLTU) to accelerate its growth.
  • Neither EQRx nor CM Life Sciences III gives any assurance that either EQRx or CM Life Sciences III or the combined company will achieve its expectations.

Super Group to Attend Jefferies Sports Betting Summit, Canaccord Digital Gaming Summit

Retrieved on: 
Monday, November 29, 2021

Participants may access a live webcast of the fireside chat on the Super Group Investor Relations site https://sghc.com/investors .

Key Points: 
  • Participants may access a live webcast of the fireside chat on the Super Group Investor Relations site https://sghc.com/investors .
  • Participants may access a live webcast of the fireside chat on the Super Group Investor Relations site https://sghc.com/investors .
  • SGHC Limited (Super Group) is the holding company for leading global online sports betting and gaming businesses: Betway, a premier online sports betting brand, and Spin, a multi-brand online casino offering.
  • Neither Super Group nor SEAH gives any assurance that either Super Group or SEAH, or the combined company, will achieve its expectations.

AutoSens Awards AEye Founder and Chief Technology Officer Luis Dussan the 2020 Vision Award

Retrieved on: 
Monday, November 29, 2021

AEye, Inc. (NASDAQ: LIDR), the global leader in adaptive, high-performance LiDAR solutions, today announced that AEye founder and CTO Luis Dussan has been awarded the 2020 Vision Award by AutoSens.

Key Points: 
  • AEye, Inc. (NASDAQ: LIDR), the global leader in adaptive, high-performance LiDAR solutions, today announced that AEye founder and CTO Luis Dussan has been awarded the 2020 Vision Award by AutoSens.
  • View the full release here: https://www.businesswire.com/news/home/20211129005081/en/
    AEye founder and CTO Luis Dussan has been awarded the 2020 Vision Award by AutoSens.
  • (Photo: Business Wire)
    Dussan, whose background is in the military and defense industries, has taken a novel approach to LiDAR sensing.
  • Im honored to accept this award on behalf of the entire team at AEye, said Dussan.

EO Charging, a Global Leader in Charging EV Fleets, Announces Virtual Analyst Day to Be Held December 14, 2021

Retrieved on: 
Monday, November 29, 2021

The live broadcast of the Virtual Analyst Day will be available via www.eocharging.com/Investors and a recording will be available shortly after the live presentation.

Key Points: 
  • The live broadcast of the Virtual Analyst Day will be available via www.eocharging.com/Investors and a recording will be available shortly after the live presentation.
  • EO Charging (EO) is a leading technology solutions provider in the EV sector.
  • EO deploys EV charging stations, hardware-agnostic cloud-based software, electrical installation, grid upgrades and ongoing service and maintenance for fleets.
  • It aims to become the global leader in charging electric van, truck, bus and car fleets.

PROG Holdings, Inc. Announces Closing of Senior Unsecured Notes Offering and Satisfaction of Tender Offer Financing Condition

Retrieved on: 
Friday, November 26, 2021

The notes are general unsecured obligations of PROG Holdings and will be guaranteed by certain of PROG Holdings existing and future domestic subsidiaries.

Key Points: 
  • The notes are general unsecured obligations of PROG Holdings and will be guaranteed by certain of PROG Holdings existing and future domestic subsidiaries.
  • The tender offer is conditioned upon, among other things, the consummation of a debt financing prior to the tender offer expiration date on terms reasonably satisfactory to PROG Holdings and resulting in gross proceeds to PROG Holdings of at least $400 million (the Financing Condition).
  • The consummation of the notes offering satisfied the Financing Condition.
  • PROG Holdings, Inc. (NYSE:PRG) is a fintech holding company headquartered in Salt Lake City, UT, that provides transparent and competitive payment options to consumers.

WOW! Unlimited Media Announces Record Quarterly EBITDA on Strong Revenue for the Third Quarter of 2021

Retrieved on: 
Thursday, November 25, 2021

Operating EBITDA for the three and nine months ended September 30, 2021, increased by $1.8 million and $6.1 million, respectively, compared to the same periods in 2020.

Key Points: 
  • Operating EBITDA for the three and nine months ended September 30, 2021, increased by $1.8 million and $6.1 million, respectively, compared to the same periods in 2020.
  • The higher operating EBITDA for the three months ended September 30, 2021, was driven primarily by the delivery of animation IP during the period.
  • These non-IFRS financial measures include operating profit or loss, operating profit or loss per share, operating EBITDA, and backlog.
  • is creating a leading animation-focused entertainment company by producing top-end content and building brands and audiences on the most engaging media platforms.

Doman Building Materials Group Ltd. Announces Normal Course Issuer Bid

Retrieved on: 
Wednesday, November 24, 2021

VANCOUVER, British Columbia, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Doman Building Materials Group Ltd. (“Doman” or the “Company”) (TSX:DBM) announced that The Toronto Stock Exchange (“TSX”) has accepted today the Company’s notice of intention to proceed with a normal course issuer bid through the facilities of the TSX and other Canadian marketplaces and alternative trading systems.

Key Points: 
  • Such forward-looking statements should therefore be construed in the light of such factors.
  • Actual events could differ materially from those projected herein and depend on a number of factors.
  • By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future.
  • Adjusted EBITDA should not be considered by an investor as an alternative to net earnings or cash flows as determined in accordance with IFRS.

RedHill Biopharma to Host Third Quarter 2021 Financial Results and Operational Highlights Webcast on November 30, 2021

Retrieved on: 
Wednesday, November 24, 2021

TEL AVIV, Israel and RALEIGH, N.C., Nov. 24, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will report its third quarter 2021 financial results and operational highlights on Tuesday, November 30, 2021.

Key Points: 
  • TEL AVIV, Israel and RALEIGH, N.C., Nov. 24, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will report its third quarter 2021 financial results and operational highlights on Tuesday, November 30, 2021.
  • The Company will host a webcast on Tuesday, November 30, 2021, at 8:30 a.m. EST, during which it will present key highlights for the third quarter of 2021.
  • The webcast including slides will be broadcast live on the Company's website, https://ir.redhillbio.com/events , and will be available for replay for 30 days.
  • RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases.

RedHill Biopharma Announces Closing of $15.5 Million Public Offering of American Depositary Shares

Retrieved on: 
Tuesday, November 23, 2021

TEL AVIV, Israel and RALEIGH, N.C., Nov. 23, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the closing of the previously announced underwritten public offering of approximately 4.7 million American Depositary Shares ("ADSs") for gross proceeds of approximately $15.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by RedHill.

Key Points: 
  • TEL AVIV, Israel and RALEIGH, N.C., Nov. 23, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the closing of the previously announced underwritten public offering of approximately 4.7 million American Depositary Shares ("ADSs") for gross proceeds of approximately $15.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by RedHill.
  • Each ADS represents ten ordinary shares, par value NIS 0.01 per share, of the Company.
  • In addition, RedHill has granted the underwriter a 30-day option to purchase up to approximately an additional 0.7 million ADSs.
  • RedHill intends to use the net proceeds of the offering to fund its commercialization activities, clinical development programs and for acquisitions and general corporate purposes.